Multimodal Biomarkers for Central Nervous System Disorders
Multimodal Biomarkers for Central Nervous System Disorders
Regular price
Checking stock...
Regular price
Checking stock...
Proud to be B-Corp
Our business meets the highest standards of verified social and environmental performance, public transparency and legal accountability to balance profit and purpose. In short, we care about people and the planet.
The feel-good place to buy books
- Free delivery in the UK
- Supporting authors with AuthorSHARE
- 100% recyclable packaging
- B Corp - kinder to people and planet
- Buy-back with World of Books - Sell Your Books
Multimodal Biomarkers for Central Nervous System Disorders by National Academies Of Sciences Engineering And Medicine
A key step towards reducing the burden of central nervous system (CNS) disorders is the identification of disease-specific biomarkers that can help predict, monitor, and guide treatment development. Recent technological advances have led to an increased number of biomarkers for different CNS disorders, providing the opportunity to generate multimodal biomarkers. While multimodal biomarkers can serve as promising tools to better diagnose and make accurate disease assessments, there remain challenges in current data collection, standardization, and validation practices that impede in their development. Recognizing the need for increased CNS biomarker integration, the National Academies Forum on Neuroscience and Nervous System Disorders hosted a public workshop in March 2023 to explore steps toward this goal, including data collection for biomarker discovery, development, validation, and assessment of clinical utility. This Proceedings of a Workshop summarizes the discussions held during the workshop. Table of Contents Front Matter 1 Introduction and Background 2 Multimodal Biomarkers for Central Nervous System Disorders 3 Exploring the State of the Science of Multimodal Biomarkers for Central Nervous System Disorders 4 Opportunities for Precision Medicine 5 Standardization and Methodology for Multimodal Biomarkers 6 Regulatory Decision Making 7 Exploring Opportunities to Move Forward Appendix A: References Appendix B: Agenda| SKU | Nicht verfügbar |
| ISBN 13 | 9780309708470 |
| ISBN 10 | 0309708478 |
| Titel | Multimodal Biomarkers for Central Nervous System Disorders |
| Autor | National Academies Of Sciences Engineering And Medicine |
| Buchzustand | Nicht verfügbar |
| Bindungsart | Paperback |
| Verlag | National Academies Press |
| Erscheinungsjahr | 2023-11-19 |
| Seitenanzahl | 82 |
| Hinweis auf dem Einband | Die Abbildung des Buches dient nur Illustrationszwecken, die tatsächliche Bindung, das Cover und die Auflage können sich davon unterscheiden. |
| Hinweis | Nicht verfügbar |